Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elicera Therapeutics presents preclinical proof-of-concept data for its iTANK-platform at the European Society of Cell & Gene Therapy Congress

Gothenburg, October 20, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, presented preclinical proof-of-concept data for the company’s iTANK-platform at the ESGCT (European Society of Gene & Cell Therapy) Virtual Congress 2021.Elicera's technology platform - iTANK (immunoTherapies Activated with NAP for efficient Killing) - has been developed to optimize the effect of CAR T-cell therapies by generating a dual mechanism-of-action. In addition to the effect of the CAR

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

Biotage acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synthesis and purification

Biotage AB (publ) (“Biotage”) has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited (“ATDBio”) based in Oxford and Southampton, UK, for a total purchase price of approx. 45 MGBP on a debt free and cash free basis (corresponding to approx. 534.4 MSEK[1]) financed through a combination of a share issue of new ordinary Biotage shares, cash at hand and a revolving credit facility. The transaction closed in connection with the entering into the share purchase agreement. The acquisition of ATDBio adds important platform solutions to

Wärtsilä and Solvang to collaborate on retrofitting carbon capture and storage system on Clipper Eos

Wärtsilä Corporation, Press release, 20 October 2021 at 9.30 AM EESTWärtsilä Exhaust Treatment and Solvang ASA, a Norwegian shipping company, have agreed on a full-scale pilot retrofit installation of a carbon capture and storage (CCS) system on one of Solvang’s ethylene carriers, the 21,000-cbm Clipper Eos.  Wärtsilä Exhaust Treatment designs the retrofitted unit while it also completes a land-based 1MW test system at its Moss headquarters in Norway. The land-based unit will be completed in autumn 2021, and the companies expect to retrofit the pilot CCS system on the Clipper Eos by 2023.

Glaston publishes the January 1– September 30, 2021 Interim Report on Thursday, October 28, 2021 at 13.00

Glaston Corporation    Press release                  20.10.2021 at 9.30Glaston Corporation will publish its January–September 2021 Interim Report on Thursday, October 28, 2021 at around 13.00 p.m. Finnish time. The report and presentation will be available as soon as possible after publishing on the Company’s internet pages at www.glaston.net.Glaston’s CEO Anders Dahlblom and CFO Päivi Lindqvist will present the financial result to analysts, investors and media representatives on the publication day at 15:00 (Finnish time) in English. The live audiocast can be accessed through the

SKF commits to net zero supply chain by 2050

Gothenburg, 20 October 2021: SKF today announces its commitment to have a supply chain with net zero greenhouse gas emissions by 2050. Rickard Gustafson, President and CEO, says: “Having already made significant progress on our journey to reducing emissions from our own operations to net zero by 2030, we are today committing to an even more ambitious goal, spanning our full supply chain. Reaching this goal will require major focus and commitment from our own operations, as well as from our suppliers, partners and customers.” As milestones towards the new 2050 goal, SKF commits to

Epiroc Capital Markets Day 2021 – Registration open

Epiroc AB, a leading productivity and sustainability partner for the mining and infrastructure industries, will host a virtual CMD for institutional investors, analysts and financial media on December 1, 2021, at 15.00 CET.The purpose of the 2.5-hour webcast is to update the financial market on Epiroc’s strategy for profitable growth. Topics such as innovation, aftermarket, operational excellence and sustainability will be covered.   Participating from Epiroc will be Helena Hedblom, President and CEO, and other members of Group Management. The CMD will be conducted in English and

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

Oslo, Norway, 20 October 2021 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces the appointment of Dr. Erik Digman Wiklund as Chief Executive Officer (CEO). Dr. Wiklund has intimate knowledge of the company and its technology having served as Chief Business Officer (CBO) and Chief Financial Officer (CFO) of Targovax since 2017.Dr. Erik Digman Wiklund said: “I am very excited to be entrusted with the opportunity to lead Targovax into the next stage of development. The ONCOS-102 program has

Herantis Pharma to Host an R&D Update Webinar on October 26, 2021

Herantis Pharma Plc, Company release, 20 October 2021 at 9:30 EEST Herantis Pharma Plc (“Herantis or the Company”), focusing on disease modifying therapies for debilitating neurodegenerative diseases will October 26[th], 2021 host an R&D Update Webinar. Herantis’ CEO Dr. Craig Cook and CSO Dr. Henri Huttunen will share progress in advancing Herantis’ HER-096 and rhCDNF programs. The R&D update will cover: · Information about Herantis’ novel biomarker focused development program · Data on efficient blood brain barrier (BBB) crossing · Results from pre-clinical experiments

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 19th October 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 25,997,195 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

SOVA chooses best city location in Gothenburg

Just in time for the Christmas shopping season, SOVA is opening a new concept store in Wallenstam’s premises at Korsgatan 14 in Gothenburg. On 667 square meters, opposite the Cathedral, Sweden’s largest retail chain in the quality beds segment will provide inspiration with its bed range.“It is really great to be able to welcome SOVA to the best city location in the Inom Vallgraven district. A nice and pleasant addition which will strengthen the city center’s offering while it will also serve as a fine compliment to the other businesses in the area,” says Marina Fritsche, Vice CEO of

MAG Interactive AB (publ) publishes Interim and Year-End Report September – August 2020/2021

MAG recorded its strongest yearly revenue in company history, mainly as a result of continued improved ARPDAU across its portfolio. Net sales in Q4 grew by 26% and ARPDAU increased by 59% compared to the same period last year.Summary of the period June 2021 – August 2021: · The Group's net sales for the period were 69,647 KSEK (55,100 KSEK), an increase of 26% compared to the same period the previous year · EBITDA for the period was 21,743 KSEK (7,664 KSEK) · Adjusted EBITDA for the period was 22,987 KSEK (596 KSEK) (adjustments for EBITDA relate to effects from acquisition costs

Getinge Q3 Report 2021: “Strong order intake and our remediation measures completed in Germany”

“Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions,” says Mattias Perjos, President & CEO at Getinge. “Our cash flow remains strong, meaning that we have strengthened our solid financial position.”Getinge’s order growth was strong compared with both 2019 and 2020. As expected, net sales declined year on year due to record-breaking deliveries of ICU ventilators in Q3 2020. Compared with Q3 2019, sales increased significantly as a result of continuing high demand for products for life supporting ECMO therapy,

Elos Medtech Interim Report January 1 - September 30, 2021

GOOD DEVELOPMENT IN ALL BUSINESS AREAS July - September 2021 · Net sales for the third quarter amounted to SEK 187.2 (147.9) million, an increase of 26.6 percent compared to the same period last year. Net sales in local currencies increased by 27.1 percent. · Operating profit for the year was SEK 24.2 (17.9) million, corresponding to an operating margin of 12.9 (12.1) percent. In the third quarter of last year government grant and subsidies due to Covid-19 had a positive impact of SEK 4.4 million on operating profit. · Operating profit includes a charge of SEK 11.8 million

Safeture sharpens the positioning towards partners within risk and crisis management and is reviewing the financial targets

• Continued growth in ARR to 30 MSEK (+33%) • Churn remained low at 1,7% • Net sales for Q3 amount to 6,6 MSEK (+18%)Summary of Interim Report The Group First nine months (2021-01-01 to 2021-09-30) • Net turnover amounted to 19 344 (15 163) TSEK, an increase of +27,6% compared to the same period last year. • Loss after financials and minority share amounted to –18 162 (-16 844) TSEK. • Loss per share before dilution amounted to -0,65 (-0,69) SEK. • Loss per share after dilution amounted to -0,60 (-0,63) SEK. Third quarter (2021-07-01 to 2021-09-30) • Net

Elkem ASA - Invitation to third quarter 2021 results presentation

Oslo, 20 October 2021 Elkem ASA will release its report for the third quarter 2021 on Wednesday, 27 October 2021 at 7.00 a.m. CET. The quarterly report and presentation material will be made available at this time at www.elkem.com In connection with the quarterly report the company will host a presentation at 8.00 a.m. CET in Felix Conference Center, Bryggetorget 3, at Aker Brygge in Oslo. The third quarter presentation can also be viewed in a live webcast.Please use https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20211027_2or access the webcast via www.elkem.com

Neste to publish its third quarter results on 27 October 2021

Neste Corporation, Press Release, 20 October 2021 at 9 a.m. (EET) Neste will publish its third quarter 2021 results on Wednesday, 27 October 2021 at approximately 9 a.m. (EET). The release will be available on the Neste website  immediately after publishing. A conference call in English for investors and analysts will be held on 27 October 2021, at 3 p.m. Finland / 1 p.m. London / 8 a.m. New York. The call-in numbers are as follows: Finland: +358 (0) 9 2311 3291, rest of Europe: +44 (0) 20 7192 8338, US: +1 646 741 3167, using

Correction: Attachment to third earnings release

Reference is made to the stock exchange release of today at 07:00 regarding the third quarter 2021 earnings release. Attached is the third quarter 2021 interim presentation.  This release contains alternative performance measures (APMs). APMs are described at www.gjensidige.no/reporting in a document named APMs GjensidigeForsikring Group Q3 2021. This release is issued by Jon Aniksdal, Communication Manager at Gjensidige Forsikring ASA.  Date and time of publication : 07:48 CET, 20.10.2021 This information is subject to disclosure under the Norwegian Securities Actsection §5-

EG7 Announces Two New Expansions to the EverQuest Franchise

EG7 today announced two new expansions to its EverQuest franchise, developed by Darkpaw Games, a Daybreak Game Company studio. Terror of Luclin for EverQuest and Visions of Vetrovia for EverQuest II are both expected to be released in December 2021. In Terror of Luclin, EverQuest’s 28th expansion, players will begin their adventure in Maiden’s Eye in their quest to thwart the plans of Mayong Mistmoore. They will journey through new zones, encounter new and familiar monsters, and complete new quests, missions and raids in reimagined regions of Luclin. EverQuest II’s Visions of Vetrovia

Tokmanni is celebrating its store in Mänttä, which is now a full-range grocery shop – It stocks everything from dinner ingredients to renovation supplies

Tokmanni     Press release     20 October 2021 at 8:30 a.m.The Tokmanni store in Mänttä now sells fresh food products, such as various fruit and snack products. Its assortment also includes food products from Finnish local and small producers. The picture here is from the Tokmanni store in Mäntsälä, where similar changes were implemented last spring. Tokmanni, Finland's largest variety discount retailer, is celebrating the expansion of its store in Mänttä  into a versatile grocery shop, with comprehensive opening offers 

EQT AB (publ) Q3 announcement 2021

Future-proofing for growth“EQT continues to leverage its thematic investment approach and we remained active in a strong market during the third quarter, signing several investments and exits. In addition, we continue to implement future-proofing measures in our portfolio companies and, combining this with strong market conditions, valuations are developing well across all key funds. We are also taking further steps to future-proof EQT AB. During the third quarter, we accelerated investments into our operating platform to manage our rapid growth. We have implemented a revision of the EQT

Veidekke ASA: Expects stable Scandinavian contracting markets for the next two years

Veidekke expects activity in the Scandinavian contracting markets to remain at current levels until the end of 2023, with generally similar headline developments all three countries.“The markets are returning to normal, pre-pandemic conditions. Our forecast in the spring that activity levels would remain high and stable has been confirmed thus far, and we expect strong momentum in the construction and civil engineering sector going forward,” says Veidekke ASA Chief Analyst Kristoffer Eide Hoen. The big topic in the construction and civil engineering industry in 2021 – both in Scandinavia

Panoro Energy – Trading Statement and Operations Update

Oslo, 20 October 2021 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to provide an update on operations and business performance in advance of the Company’s third quarter results which are due for release on 22 November 2021. Financial and production information within this announcement remains subject to final reconciliation. John Hamilton, CEO of Panoro, commented today: “We are pleased to update on the good progress being made across our portfolio of production and development assets. With five new production wells on schedule to start up in the fourth quarter at Block

Wihlborgs’ interim report for January–September 2021 will be presented on 22 October 2021 – invitation to presentation

Wihlborgs’ interim report for January–September 2021 will be published on 22 October 2021, at 7:30 a.m. CEST. Wihlborgs invites press, investors and analysts to a telephone conference at 8:30 a.m. CEST on the same date.During the telephone conference/webcast, Ulrika Hallengren, CEO of Wihlborgs, and Arvid Liepe, CFO, will present Wihlborgs’ interim report for January–September 2021. Following the presentation, there will be the opportunity to pose questions. The presentation will be held in English.  Date:             22 October Time:             The report will be published at 7:30 a.

There are no items matching the current filter
There are no more items matching the current filter
Back to top